Skip to main content

Articles

Page 4 of 27

  1. Authors: Qingyi Ma, Zhen Zhao, Abhay P. Sagare, Yingxi Wu, Min Wang, Nelly Chuqui Owens, Philip B. Verghese, Joachim Herz, David M. Holtzman and Berislav V. Zlokovic
    Citation: Molecular Neurodegeneration 2022 17:71
    Content type: Correction Published on:

    The Correction to this article has been published in Molecular Neurodegeneration 2024 19:27

    The original article was published in Molecular Neurodegeneration 2018 13:57

  8. Authors: Yu-Hui Liu, Ye-Ran Wang, Qing-Hua Wang, Juan Liu and Yan-Jiang Wang
    Citation: Molecular Neurodegeneration 2022 17:64
    Content type: Letter to the Editor Published on:

    The original article was published in Molecular Neurodegeneration 2022 17:63

    The Research article to this article has been published in Molecular Neurodegeneration 2021 16:48

  9. Authors: Rahmouni Nesrine, Rosa-Neto Pedro and Brunet Alain
    Citation: Molecular Neurodegeneration 2022 17:63
    Content type: Letter to the Editor Published on:

    The Letter to the Editor to this article has been published in Molecular Neurodegeneration 2022 17:64

    The original article was published in Molecular Neurodegeneration 2021 16:48

  10. ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of the most influential risk factors for ...

    Authors: Rosalía Fernández-Calle, Sabine C. Konings, Javier Frontiñán-Rubio, Juan García-Revilla, Lluís Camprubí-Ferrer, Martina Svensson, Isak Martinson, Antonio Boza-Serrano, José Luís Venero, Henrietta M. Nielsen, Gunnar K. Gouras and Tomas Deierborg
    Citation: Molecular Neurodegeneration 2022 17:62
    Content type: Review Published on:

  11. Alzheimer’s Disease (AD) affects millions globally, but therapy development is lagging. New experimental systems that monitor neuronal functions in conditions approximating the AD brain may be beneficial for i...

    Authors: Yi-Chen Hsieh, Joseph Negri, Amy He, Richard V. Pearse II, Lei Liu, Duc M. Duong, Lori B. Chibnik, David A. Bennett, Nicholas T. Seyfried and Tracy L. Young-Pearse
    Citation: Molecular Neurodegeneration 2022 17:61
    Content type: Research article Published on:

  12. Although ɑ-synuclein (ɑ-syn) spreading in age-related neurodegenerative diseases such as Parkinson’s disease (PD) and Dementia with Lewy bodies (DLB) has been extensively investigated, the role of aging in the...

    Authors: Michiyo Iba, Ross A. McDevitt, Changyoun Kim, Roshni Roy, Dimitra Sarantopoulou, Ella Tommer, Byron Siegars, Michelle Sallin, Somin Kwon, Jyoti Misra Sen, Ranjan Sen and Eliezer Masliah
    Citation: Molecular Neurodegeneration 2022 17:60
    Content type: Research article Published on:

  14. Alzheimer’s disease (AD) is a neurodegenerative disorder that manifests sequential Aβ and tau brain pathology with age-dependent onset. Variants in the microglial immune receptor TREM2 are associated with enha...

    Authors: Bing Zhu, Yan Liu, Spring Hwang, Kailey Archuleta, Huijie Huang, Alex Campos, Rabi Murad, Juan Piña-Crespo, Huaxi Xu and Timothy Y. Huang
    Citation: Molecular Neurodegeneration 2022 17:58
    Content type: Research article Published on:

  15. The aggregation and spread of α-synuclein (α-Syn) protein and related neuronal toxicity are the key pathological features of Parkinson’s disease (PD) and Lewy body dementia (LBD). Studies have shown that patho...

    Authors: Kai Chen, Yuka A. Martens, Axel Meneses, Daniel H. Ryu, Wenyan Lu, Ana Caroline Raulin, Fuyao Li, Jing Zhao, Yixing Chen, Yunjung Jin, Cynthia Linares, Marshall Goodwin, Yonghe Li, Chia-Chen Liu, Takahisa Kanekiyo, David M. Holtzman…
    Citation: Molecular Neurodegeneration 2022 17:57
    Content type: Research article Published on:

  17. TYROBP (also known as DAP12 or KARAP) is a transmembrane adaptor protein initially described as a receptor-activating subunit component of natural killer (NK) cells. TYROBP is expressed in numerous cell types,...

    Authors: Jean-Vianney Haure-Mirande, Mickael Audrain, Michelle E. Ehrlich and Sam Gandy
    Citation: Molecular Neurodegeneration 2022 17:55
    Content type: Review Published on:

  18. Amyloid plaque deposition and axonal degeneration are early events in AD pathogenesis. Aβ disrupts microtubules in presynaptic dystrophic neurites, resulting in the accumulation of impaired endolysosomal and a...

    Authors: Leah K. Cuddy, Alia O. Alia, Miranda A. Salvo, Sidhanth Chandra, Tom N. Grammatopoulos, Craig J. Justman, Peter T. Lansbury Jr, Joseph R. Mazzulli and Robert Vassar
    Citation: Molecular Neurodegeneration 2022 17:54
    Content type: Research article Published on:

  19. The Amyloid theory of Alzheimer’s disease (AD) suggests that the deposition of Amyloid β (Aβ) in the brain triggers a chain of events, involving the deposition of phosphorylated Tau and other misfolded protein...

    Authors: Tal Ganz, Nina Fainstein and Tamir Ben-Hur
    Citation: Molecular Neurodegeneration 2022 17:53
    Content type: Review Published on:

  20. Genetic mutations in beta-glucocerebrosidase (GBA) represent the major genetic risk factor for Parkinson’s disease (PD). GBA participates in both the endo-lysosomal pathway and the immune response, two important ...

    Authors: Giulietta Maria Riboldi, Ricardo A. Vialle, Elisa Navarro, Evan Udine, Katia de Paiva Lopes, Jack Humphrey, Amanda Allan, Madison Parks, Brooklyn Henderson, Kelly Astudillo, Charalambos Argyrou, Maojuan Zhuang, Tamjeed Sikder, J. Oriol Narcis, Shilpa Dilip Kumar, William Janssen…
    Citation: Molecular Neurodegeneration 2022 17:52
    Content type: Research article Published on:

  22. Living organisms constantly need to adapt to their surrounding environment and have evolved sophisticated mechanisms to deal with stress. Mitochondria and lysosomes are central organelles in the response to en...

    Authors: Martin Lang, Peter P. Pramstaller and Irene Pichler
    Citation: Molecular Neurodegeneration 2022 17:50
    Content type: Review Published on:

  24. Parkinson’s disease (PD) is genetically associated with the H1 haplotype of the MAPT 17q.21.31 locus, although the causal gene and variants underlying this association have not been identified.

    Authors: Kathryn R. Bowles, Derian A. Pugh, Yiyuan Liu, Tulsi Patel, Alan E. Renton, Sara Bandres-Ciga, Ziv Gan-Or, Peter Heutink, Ari Siitonen, Sarah Bertelsen, Jonathan D. Cherry, Celeste M. Karch, Steven J. Frucht, Brian H. Kopell, Inga Peter, Y. J. Park…
    Citation: Molecular Neurodegeneration 2022 17:48
    Content type: Research article Published on:

  25. Despite its identification as a key checkpoint regulator of microglial activation in Alzheimer’s disease, the overarching role of CX3CR1 signaling in modulating mechanisms of Aβ driven neurodegeneration, inclu...

    Authors: Shweta S. Puntambekar, Miguel Moutinho, Peter Bor-Chian Lin, Vaishnavi Jadhav, Danika Tumbleson-Brink, Ananya Balaji, Martin Alvarado Benito, Guixiang Xu, Adrian Oblak, Cristian A. Lasagna-Reeves, Gary E. Landreth and Bruce T. Lamb
    Citation: Molecular Neurodegeneration 2022 17:47
    Content type: Research article Published on:

  26. A constant metabolism and energy supply are crucial to all organs, particularly the brain. Age-dependent neurodegenerative diseases, such as Parkinson’s disease (PD), are associated with alterations in cellula...

    Authors: Murad Al-Nusaif, Yuting Yang, Song Li, Cheng Cheng and Weidong Le
    Citation: Molecular Neurodegeneration 2022 17:46
    Content type: Review Published on:

  28. Microglia plays crucial roles in Alzheimer’s disease (AD) development. Triggering receptor expressed on myeloid cells 2 (TREM2) in association with DAP12 mediates signaling affecting microglia function. Here w...

    Authors: Peng Zhao, Yuanzhong Xu, Lu-Lin Jiang, Xuejun Fan, Zhiqiang Ku, Leike Li, Xiaoye Liu, Mi Deng, Hisashi Arase, Jay-Jiguang Zhu, Timothy Y. Huang, Yingjun Zhao, Chengcheng Zhang, Huaxi Xu, Qingchun Tong, Ningyan Zhang…
    Citation: Molecular Neurodegeneration 2022 17:44
    Content type: Research article Published on:

  29. A consequence of our progressively ageing global population is the increasing prevalence of worldwide age-related cognitive decline and dementia. In the absence of effective therapeutic interventions, identify...

    Authors: Emily Connell, Gwenaelle Le Gall, Matthew G. Pontifex, Saber Sami, John F. Cryan, Gerard Clarke, Michael Müller and David Vauzour
    Citation: Molecular Neurodegeneration 2022 17:43
    Content type: Review Published on:

  30. Apolipoprotein E4 (APOE4) is associated with a greater response to neuroinflammation and the risk of developing late-onset Alzheimer’s disease (AD), but the mechanisms for this association are not clear. The acti...

    Authors: Shaowei Wang, Boyang Li, Victoria Solomon, Alfred Fonteh, Stanley I. Rapoport, David A. Bennett, Zoe Arvanitakis, Helena C. Chui, Patrick M. Sullivan and Hussein N. Yassine
    Citation: Molecular Neurodegeneration 2022 17:42
    Content type: Research article Published on:

  31. Genetic mutations underlying familial Alzheimer’s disease (AD) were identified decades ago, but the field is still in search of transformative therapies for patients. While mouse models based on overexpression...

    Authors: Dan Xia, Steve Lianoglou, Thomas Sandmann, Meredith Calvert, Jung H. Suh, Elliot Thomsen, Jason Dugas, Michelle E. Pizzo, Sarah L. DeVos, Timothy K. Earr, Chia-Ching Lin, Sonnet Davis, Connie Ha, Amy Wing-Sze Leung, Hoang Nguyen, Roni Chau…
    Citation: Molecular Neurodegeneration 2022 17:41
    Content type: Research article Published on:

  32. Triggering receptor expressed on myeloid cells 2 (TREM2) is a single-pass transmembrane immune receptor that is mainly expressed on microglia in the brain and macrophages in the periphery. Recent studies have ...

    Authors: Rui-Yang Li, Qi Qin, Han-Chen Yang, Ying-Ying Wang, Ying-Xin Mi, Yun-Si Yin, Meng Wang, Chao-Ji Yu and Yi Tang
    Citation: Molecular Neurodegeneration 2022 17:40
    Content type: Review Published on:

  35. Authors: Pieter Jelle Visser, Lianne M. Reus, Johan Gobom, Iris Jansen, Ellen Dicks, Sven J. van der Lee, Magda Tsolaki, Frans R. J. Verhey, Julius Popp, Pablo Martinez-Lage, Rik Vandenberghe, Alberto Lleó, José Luís Molinuevo, Sebastiaan Engelborghs, Yvonne Freund-Levi, Lutz Froelich…
    Citation: Molecular Neurodegeneration 2022 17:37
    Content type: Correction Published on:

    The original article was published in Molecular Neurodegeneration 2022 17:27

  38. The dietary consumption of cuprizone – a copper chelator – has long been known to induce demyelination of specific brain structures and is widely used as model of multiple sclerosis. Despite the extensive use ...

    Authors: Martin Zirngibl, Peggy Assinck, Anastasia Sizov, Andrew V. Caprariello and Jason R. Plemel
    Citation: Molecular Neurodegeneration 2022 17:34
    Content type: Review Published on:

  39. The BIN1 locus contains the second-most significant genetic risk factor for late-onset Alzheimer’s disease. BIN1 undergoes alternate splicing to generate tissue- and cell-type-specific BIN1 isoforms, which regula...

    Authors: Ari Sudwarts, Supriya Ramesha, Tianwen Gao, Moorthi Ponnusamy, Shuai Wang, Mitchell Hansen, Alena Kozlova, Sara Bitarafan, Prateek Kumar, David Beaulieu-Abdelahad, Xiaolin Zhang, Lisa Collier, Charles Szekeres, Levi B. Wood, Jubao Duan, Gopal Thinakaran…
    Citation: Molecular Neurodegeneration 2022 17:33
    Content type: Research article Published on:

  40. Genetic variation at the PTK2B locus encoding the protein Pyk2 influences Alzheimer’s disease risk. Neurons express Pyk2 and the protein is required for Amyloid-β (Aβ) peptide driven deficits of synaptic function...

    Authors: A. Harrison Brody, Sarah Helena Nies, Fulin Guan, Levi M. Smith, Bandhan Mukherjee, Santiago A. Salazar, Suho Lee, Tu Kiet T. Lam and Stephen M. Strittmatter
    Citation: Molecular Neurodegeneration 2022 17:32
    Content type: Research article Published on:

    The Correction to this article has been published in Molecular Neurodegeneration 2022 17:56

  42. Neuronal uptake and subsequent spread of proteopathic seeds, such as αS (alpha-synuclein), Tau, and TDP-43, contribute to neurodegeneration. The cellular machinery participating in this process is poorly under...

    Authors: Jiang Zhu, Sara Pittman, Dhruva Dhavale, Rachel French, Jessica N. Patterson, Mohamed Salman Kaleelurrrahuman, Yuanzi Sun, Jaime Vaquer-Alicea, Gianna Maggiore, Christoph S. Clemen, William J. Buscher, Jan Bieschke, Paul Kotzbauer, Yuna Ayala, Marc I. Diamond, Albert A. Davis…
    Citation: Molecular Neurodegeneration 2022 17:30
    Content type: Research article Published on:

  43. Synapse degeneration is an early event in pathological frontotemporal lobar degeneration (FTLD). Consequently, a surrogate marker of synapse loss could be used to monitor early pathologic changes in patients w...

    Authors: Alba Cervantes González, David J. Irwin, Daniel Alcolea, Corey T. McMillan, Alice Chen-Plotkin, David Wolk, Sònia Sirisi, Oriol Dols-Icardo, Marta Querol-Vilaseca, Ignacio Illán-Gala, Miguel Angel Santos-Santos, Juan Fortea, Edward B. Lee, John Q. Trojanowski, Murray Grossman, Alberto Lleó…
    Citation: Molecular Neurodegeneration 2022 17:29
    Content type: Research article Published on:

  44. Tauopathies are a class of neurodegenerative disorders characterized by neuronal and/or glial tau-positive inclusions.

    Authors: Yi Zhang, Kai-Min Wu, Liu Yang, Qiang Dong and Jin-Tai Yu
    Citation: Molecular Neurodegeneration 2022 17:28
    Content type: Review Published on:

  45. Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer’s disease (AD) and is considered to result from neurodegeneration. T-tau levels, however, can be increased in very ...

    Authors: Pieter Jelle Visser, Lianne M. Reus, Johan Gobom, Iris Jansen, Ellen Dicks, Sven J. van der Lee, Magda Tsolaki, Frans R. J. Verhey, Julius Popp, Pablo Martinez-Lage, Rik Vandenberghe, Alberto Lleó, José Luís Molinuevo, Sebastiaan Engelborghs, Yvonne Freund-Levi, Lutz Froelich…
    Citation: Molecular Neurodegeneration 2022 17:27
    Content type: Research article Published on:

    The Correction to this article has been published in Molecular Neurodegeneration 2022 17:37

  46. Microglia, the resident immune cells of the brain, play a critical role in numerous diseases, but are a minority cell type and difficult to genetically manipulate in vivo with viral vectors and other approache...

    Authors: Mika P. Cadiz, Tanner D. Jensen, Jonathon P. Sens, Kuixi Zhu, Won-Min Song, Bin Zhang, Mark Ebbert, Rui Chang and John D. Fryer
    Citation: Molecular Neurodegeneration 2022 17:26
    Content type: Research article Published on:

  47. The retina, as part of the central nervous system (CNS) with limited capacity for self-reparation and regeneration in mammals, is under cumulative environmental stress due to high-energy demands and rapid prot...

    Authors: Todd McLaughlin, Andy Medina, Jacob Perkins, Maria Yera, Joshua J. Wang and Sarah X. Zhang
    Citation: Molecular Neurodegeneration 2022 17:25
    Content type: Review Published on:

  49. Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address...

    Authors: Lauren K. Wareham, Shane A. Liddelow, Sally Temple, Larry I. Benowitz, Adriana Di Polo, Cheryl Wellington, Jeffrey L. Goldberg, Zhigang He, Xin Duan, Guojun Bu, Albert A. Davis, Karthik Shekhar, Anna La Torre, David C. Chan, M. Valeria Canto-Soler, John G. Flanagan…
    Citation: Molecular Neurodegeneration 2022 17:23
    Content type: Review Published on:

  50. Neuroinflammation is an important hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). An inflammatory reaction to neuronal injury is deemed vital for neuronal health a...

    Authors: Pegah Masrori, Jimmy Beckers, Helena Gossye and Philip Van Damme
    Citation: Molecular Neurodegeneration 2022 17:22
    Content type: Review Published on:
Submit manuscript

Follow

  • ISSN: 1750-1326 (electronic)

Molecular Neurodegeneration

ISSN: 1750-1326